MRKR - Marker Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

MRKR is currently covered by 1 analysts with an average price target of $23.7. This is a potential upside of $22.1 (1381.25%) from yesterday's end of day stock price of $1.6.

Marker Therapeutics's activity chart (see below) currently has 12 price targets and 14 ratings on display. The stock rating distribution of MRKR is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 6.25% with an average time for these price targets to be met of 1.75 days.

Highest price target for MRKR is $11, Lowest price target is $11, average price target is $11.

Most recent stock forecast was given by AYDIN HUSEYNOV from LADENBURG on 21-Oct-2024. First documented stock forecast 22-Oct-2018.

Best performing analysts who are covering MRKR - Marker Therapeutics:

Edward Tenthoff Matthew Biegler Joseph Catanzaro Aydin Huseynov

Currently out of the existing stock ratings of MRKR, 2 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$11

$9.23 (521.47%)

$11

7 months 23 days ago
(21-Oct-2024)

0/2 (0%)

$7.3 (197.30%)

Buy

$15

$13.23 (747.46%)

3 years 17 days ago
(27-May-2022)

0/1 (0%)

$12 (400.00%)

Buy

3 years 3 months 28 days ago
(17-Feb-2022)

0/1 (0%)

$67.7 (82.26%)

Buy

$25

4 years 2 months 19 days ago
(25-Mar-2021)

1/4 (25%)

$1.4 (5.93%)

7

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is MRKR (Marker Therapeutics) average time for price targets to be met?

On average it took 1.75 days on average for the stock forecasts to be realized with a an average price target met ratio 6.25

Which analyst has the current highest performing score on MRKR (Marker Therapeutics) with a proven track record?

EDWARD TENTHOFF

Which analyst has the current lower performing score on MRKR (Marker Therapeutics) with a proven track record?

AYDIN HUSEYNOV

Which analyst has the most public recommendations on MRKR (Marker Therapeutics)?

Edward Tenthoff works at PIPER SANDLER and has 16 price targets and 10 ratings on MRKR

Which analyst is the currently most bullish on MRKR (Marker Therapeutics)?

Joseph Catanzaro with highest potential upside - $13.23

Which analyst is the currently most reserved on MRKR (Marker Therapeutics)?

Edward Tenthoff with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?